...
首页> 外文期刊>BMC Psychiatry >Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial
【24h】

Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial

机译:靶控制输注和电腐蚀治疗期间异丙酚麻醉手动输注的比较:开放式随机对照试验

获取原文
           

摘要

Target-controlled infusion (TCI) of propofol is a well-established method of procedural sedation and has been used in Japan for anesthesia during electroconvulsive therapy (ECT). However, the usefulness of the TCI of propofol for ECT has yet to be determined. This study aimed to compare the TCI and manual infusion (MI) of propofol anesthesia during ECT. A total of forty psychiatric inpatients receiving bitemporal ECT were enrolled in the present study and randomized into the TCI group (N?=?20) and the MI group (N?=?20). Clinical Global Impression (CGI) and Montreal Cognitive Assessment (MoCA) scores were measured before and after ECT. The clinical outcomes, anesthesia-related variables, and ECT-related variables were compared between the two groups. Generalized estimating equations (GEEs) were used to model the comparison throughout the course of ECT. A total of 36 subjects completed the present study, with 18 subjects in each group. Both the groups didn’t significantly differ in the post-ECT changes in CGI and MoCA scores. However, concerning MoCA scores after 6 treatments of ECT, the MI group had improvement while the TCI group had deterioration. Compared with the MI group, the TCI group had higher doses of propofol, and longer procedural and recovery time. The TCI group seemed to have more robust seizures in the early course of ECT but less robust seizures in the later course of ECT compared with the MI group. The present study does not support the use of TCI of propofol for anesthesia of ECT. (ClinicalTrials.gov): NCT03863925 . Registered March 5, 2019 - Retrospectively registered.
机译:异丙酚的靶控制输注(TCI)是一种良好的程序镇静方法,并在日本在电耦合治疗期间用于麻醉(ECT)。然而,尚未确定异丙酚的TCI的有用性尚未确定。本研究旨在比较ECT期间异丙酚麻醉的TCI和手动输注(MI)。在本研究中注册了接受贝蛋白ECT的四十个精神科入住剂,并随机进入TCI组(N?=?20)和MI组(n?=?20)。在ECT之前和之后测量临床全球印象(CGI)和蒙特利尔认知评估(MOCA)分数。在两组之间比较了临床结果,麻醉相关的变量和与相关的变量进行了相关的变量。广义估计方程(GEE)用于在整个ECT过程中进行模拟比较。共有36项受试者完成了本研究,每组18名受试者。在CGI和MOCA分数的后医变化中,这两个组都没有显着差异。然而,关于ECT治疗后的MOCA评分,MI组在TCI组劣化时具有改善。与MI组相比,TCI组具有较高剂量的异丙酚,更长的程序和恢复时间。与MI集团相比,TCI集团似乎在ECT早期进程中具有更强大的癫痫发作,但在后期的ECT过程中令人稳健的癫痫发作。本研究不支持使用异丙酚的TCI对ECT麻醉。 (ClinicalTrials.gov):NCT03863925。注册2019年3月5日 - 回顾性注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号